Artificial Intelligence and Anticancer Drug Development—Keep a Cool Head

Bailleux, Caroline and Gal, Jocelyn and Chamorey, Emmanuel and Mograbi, Baharia and Milano, Gérard (2024) Artificial Intelligence and Anticancer Drug Development—Keep a Cool Head. Pharmaceutics, 16 (2). p. 211. ISSN 1999-4923

[thumbnail of pharmaceutics-16-00211-v2.pdf] Text
pharmaceutics-16-00211-v2.pdf - Published Version

Download (677kB)

Abstract

Artificial intelligence (AI) is progressively spreading through the world of health, particularly in the field of oncology. AI offers new, exciting perspectives in drug development as toxicity and efficacy can be predicted from computer-designed active molecular structures. AI-based in silico clinical trials are still at their inception in oncology but their wider use is eagerly awaited as they should markedly reduce durations and costs. Health authorities cannot neglect this new paradigm in drug development and should take the requisite measures to include AI as a new pillar in conducting clinical research in oncology.

Item Type: Article
Subjects: Oalibrary Press > Multidisciplinary
Depositing User: Managing Editor
Date Deposited: 01 Feb 2024 06:06
Last Modified: 01 Feb 2024 06:06
URI: http://asian.go4publish.com/id/eprint/3637

Actions (login required)

View Item
View Item